Parallel Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26K | Sell |
|
|||||
|
2025
Q1 | $94.4K | Buy |
|
|||||
|
2024
Q4 | $44.4K | Sell |
|
|||||
|
2024
Q3 | $75.2K | Sell |
|
|||||
|
2024
Q2 | $176K | Sell |
|
|||||
|
2024
Q1 | $207K | Buy |
|
|||||
|
2023
Q4 | $212K | Sell |
|
|||||
|
2023
Q3 | $208K | Sell |
|
|||||
|
2023
Q2 | $469K | Sell |
|
|||||
|
2023
Q1 | $585K | Buy |
|
|||||
|
2022
Q4 | $515K | Buy |
|
|||||
|
2022
Q3 | $384K | Buy |
|
|||||
|
2022
Q2 | $103K | Buy |
|
|||||
|
2022
Q1 | $95K | Sell |
|
|||||
|
2021
Q4 | $130K | Buy |
|
|||||
|
2021
Q3 | $56K | Buy |
|
|||||
|
2021
Q2 | $58K | Buy |
|
|||||
|
2021
Q1 | $44K | Hold |
|
|||||
|
2020
Q4 | $51K | Sell |
|
|||||
|
2020
Q3 | $53K | Buy |
|
|||||
|
2020
Q2 | $59K | Buy |
|
|||||
|
2020
Q1 | $34K | Buy |
|
|||||
|
2019
Q4 | $32K | Hold |
|
|||||
|
2019
Q3 | $25K | Buy |
|
|||||
|
2019
Q2 | $30K | Sell |
|
|||||
|
2019
Q1 | $37K | Sell |
|
|||||
|
2018
Q4 | $40K | Sell |
|
|||||
|
2018
Q3 | $337K | Buy |
|
|||||
|
2018
Q2 | $280K | Buy |
|
|||||
|
2018
Q1 | $80K | Sell |
|
|||||
|
2017
Q4 | $92K | Buy |
|
|||||
|
2017
Q3 | $80K | Sell |
|
|||||
|
2017
Q2 | $90K | Sell |
|
|||||
|
2017
Q1 | $100K | Buy |
|
|||||
|
2016
Q4 | $76K | Buy |
|